BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2893451)

  • 1. Long term experience of salazopyrin EN in rheumatoid arthritis (RA).
    Farr M; Bacon PA; Coppock J; Scott DL
    Scand J Rheumatol Suppl; 1987; 64():37-47. PubMed ID: 2893451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
    Winkler V
    Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis.
    Taggart AJ; McDermott B; Delargy M; Elborn S; Forbes J; Roberts SD; Ahnfelt NO
    Scand J Rheumatol Suppl; 1987; 64():29-36. PubMed ID: 2893450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
    Donovan S; Hawley S; MacCarthy J; Scott DL
    Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of long-term treatment of rheumatoid arthritis with second-line agents.
    McConkey B
    Scand J Rheumatol Suppl; 1987; 64():25-8. PubMed ID: 2893449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salazopyrin in rheumatoid arthritis.
    McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
    Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine: II. Some notes on the discovery and development of salazopyrin.
    Svartz N
    Am J Gastroenterol; 1988 May; 83(5):497-503. PubMed ID: 2896459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is a disease modifying antirheumatic drug?
    Hepburn B
    J Rheumatol Suppl; 1988 Sep; 16():40-2. PubMed ID: 2903926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmachem's salazopyrine in rheumatoid arthritis].
    Konstantinova M; Konstantinova V
    Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulfasalazine in rheumatology].
    Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
    Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ
    J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid spondylarthritis with salazosulfapyridine].
    Hilliquin P; Munoz A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1991; 58(7):535-41. PubMed ID: 1681585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfasalazine: a review of its use in the management of rheumatoid arthritis.
    Plosker GL; Croom KF
    Drugs; 2005; 65(13):1825-49. PubMed ID: 16114981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.
    Rantalaiho V; Puolakka K; Korpela M; Hannonen P; Möttönen T
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S27-31. PubMed ID: 23073350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.
    J Rheumatol; 1992 Nov; 19(11):1672-7. PubMed ID: 1362778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.
    Walsh AM; Wechalekar MD; Guo Y; Yin X; Weedon H; Proudman SM; Smith MD; Nagpal S
    PLoS One; 2017; 12(9):e0183928. PubMed ID: 28863153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulfasalazine in rheumatoid arthritis].
    Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
    Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salazosulfapyridine (sulfasalazine)in inflammatory rheumatic diseases].
    Pelísková Z; Trnavský K
    Cas Lek Cesk; 1989 Jul; 128(30):949-51. PubMed ID: 2571417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.